Wexler Boley & Elgersma LLP, Miller Law LLC, Hilliard Shadowen LLP, Motley Rice LLC, and Spector Roseman & Kodroff P.C. Announce a $30 Million Class Action Settlement for Those Who May Have Purchased or Provided Reimbursement for the Drug Suboxone or Gene
The Court has preliminarily approved a proposed settlement between the Class and Indivior (the "Settlement").
- The Court has preliminarily approved a proposed settlement between the Class and Indivior (the "Settlement").
- The proposed Settlement will provide for the payment of $30 million (the "Settlement Fund") to resolve the Class claims against Indivior.
- The deadlines contained in this Notice may be amended by Court Order, so check the Settlement website for any updates.
- SOURCE Wexler Boley & Elgersma LLP, Miller Law LLC, Hilliard Shadowen LLP, Motley Rice LLC, and Spector Roseman & Kodroff P.C.